Your browser doesn't support javascript.
loading
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma.
Salazar, James; Saxena, Varun; Kahn, James G; Roberts, John P; Mehta, Neil; Volk, Michael; Lai, Jennifer C.
Affiliation
  • Salazar J; 1 Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, CA. 2 Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA. 3 Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. 4 Division of Gastroenterology and Hepatology, Transplantation Institute, Loma Linda University Health, Loma Linda, CA.
Transplantation ; 101(5): 1001-1008, 2017 05.
Article in En | MEDLINE | ID: mdl-27926593

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Liver Transplantation / Cost-Benefit Analysis / Carcinoma, Hepatocellular / Hepatitis C, Chronic / Liver Cirrhosis / Liver Neoplasms Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Transplantation Year: 2017 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Liver Transplantation / Cost-Benefit Analysis / Carcinoma, Hepatocellular / Hepatitis C, Chronic / Liver Cirrhosis / Liver Neoplasms Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Transplantation Year: 2017 Document type: Article Affiliation country: Canada Country of publication: United States